Follicular lymphoma (FL) is the most common indolent non-hodgkin lymphoma. Most
patients with FL are diagnosed with advanced disease and are considered incurable. The …

Follicular lymphoma (FL) is the most common subtype of indolent non-Hodgkin lymphoma in
Western countries. While FL is generally incurable, standard initial therapies are associated …

Follicular lymphoma (FL) is a heterogeneous disease with varying prognosis owing to
differences in clinical, laboratory, and disease parameters. Although generally considered …

Aim The prognosis and treatment options for follicular lymphoma (FL) remain heterogenous.
This study aimed to analyze the prognostic impact of rituximab maintenance and evaluate …

Opinion Statement The optimal initial treatment of follicular lymphoma (FL) is not known, and
initial management of patients varies considerably between providers and institutions. The …

Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …

Background Follicular lymphomas (FLs) are a heterogeneous group of lymphomas. No
standard of care exists, and the management of these patients is highly individualized …

Follicular lymphoma (FL) is a heterogeneous disease with varying prognosis owing to
differences in clinical, laboratory, and disease parameters. Although generally considered …

Follicular lymphoma (FL) is the most common of the indolent non-Hodgkins lymphomas.
Despite remaining an incurable disease, overall survival improvements have been noted in …

Follicular lymphoma is a heterogeneous B-cell lymphoma both in presentation and at
progression. For most patients it is a chronic, relapsing indolent disease with overall survival …